P

PUMA BIOTECHNOLOGY INCPBYI

Puma Biotechnology, Inc. is a biopharmaceutical company with a focus on the development and commercialization of innovative products to enhance cancer care. Puma in-licensed the global development and commercialization rights to PB272 (neratinib, oral) in.

US StocksHealthcareSmall CapBiotechnology

PBYI の価格トレンド

PUMA BIOTECHNOLOGY INC · TradingView フルチャート

NASDAQ:PBYI

オンチェーンアクティビティ